Material share-based payments

Hong Kong IPO disclosure precedents · 150 companies, 150 items

share-based payment expenses material to results, and their effect on profit

2023-09-18Prospectus
ZX Inc.中旭未来09890.HK

We expect to experience a decrease in net profit in 2023 compared to 2022, primarily attributable to an increase in share-based compensation resulting from the new options granted under the Pre- IPO Share Option Plan.

Summary · p. 33

We operate a share award scheme for the purpose of providing incentives and rewards to eligible participants who contribute to the success of our operations.

Financial Information · p. 398

Share-based compensations are non-cash in nature and do not result in cash outflow, and the adjustment has been consistently made during the Track Record Period.

Financial Information · p. 401
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-09-14Prospectus
TUHU Car Inc.途虎养车股份有限公司09690.HK

Share-based payment expenses primarily represent the non-cash employee benefit expenses incurred in connection with our 2019 Share Incentive Plan.

Summary · p. 14

The fair values of equity instrument granted are determined by an external valuer using a binomial model, further details of which are given in note 39 to the Accountants' Report in Appendix I to this document.

Financial Information · p. 379
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-09-13Prospectus
WUHAN YZY BIOPHARMA CO., LTD.武汉友芝友生物制药股份有限公司02496.HK

For the years ended December 31, 2021 and 2022 and the five months ended May 31, 2023, our research and development expenses amounted to RMB112.9 million, RMB157.3 million and RMB63.7 million, respectively, of which our non-cash share-based payments were RMB25.0 million, nil and nil for the same periods, respectively.

Financial Information · p. 489

For the years ended December 31, 2021 and 2022 and the five months ended May 31, 2023, our administrative expenses amounted to RMB31.5 million, RMB20.5 million and RMB6.8 million, respectively, of which our non-cash share-based payments were RMB14.6 million, RMB1.6 million and nil for the same periods, respectively.

Financial Information · p. 489
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-08-24Prospectus
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.宜明昂科生物医药技术(上海)股份有限公司01541.HK

Our research and development expenses amounted to RMB176.0 million, RMB277.3 million, and RMB75.0 million in 2021, 2022 and the four months ended April 30, 2023, respectively, of which our non-cash share-based payments were RMB13.7 million, RMB40.7 million, and RMB13.4 million in 2021, 2022, and the four months ended April 30, 2023, respectively.

Financial Information · p. 374

Our administrative expenses amounted to RMB48.3 million, RMB92.8 million, and RMB28.5 million in 2021, 2022 and the four months ended April 30, 2023, respectively, of which our non-cash share-based payments were RMB20.3 million, RMB63.1 million and RMB16.7 million in 2021, 2022 and the four months ended April 30, 2023, respectively.

Financial Information · p. 374
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-04-28Prospectus
Plus Group Holdings Inc.普乐师集团控股有限公司02486.HK

Our Company had granted with an aggregate of 20,000 underlying Shares, which has been adjusted to 1,000,000 underlying Shares after the completion of the Share Subdivision, representing 0.80% of the issued Shares immediately upon completion of the Global Offering (assuming the Over-allotment Option is not exercised) on 31 March 2023.

Summary · p. 19

It is expected that the grant of the RSU will cause our Group to incur share-based payment expenses during the vesting period.

Summary · p. 19
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-03-30Prospectus
Beisen Holding Limited北森控股有限公司09669.HK

Share-based payments for ESOP purposes relates to the share rewards we offered to our employees, which is a non-cash expense.

Summary · p. 9

Share-based payments for non-ESOP purposes arise from certain share exchange and share repurchase transactions, and transactions among shareholders.

Summary · p. 9

We expect that we may still record net loss and adjusted net loss (non-IFRS measure) in the near future, primarily due to the following reasons: (i) spending on selling and marketing to acquire customers and strengthen our brand awareness; (ii) investments in research and development to further enhance our HCM solutions and infrastructures; and (iii) employee related expenses due to rising personnel to support our business expansion, and the increased compensation levels including share-based compensation we provide to a select number of talents to incentivize them.

Summary · p. 19
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-03-16Prospectus
DPC Dash Ltd达势股份有限公司01405.HK

For the years ended December 31, 2020, 2021 and 2022, we recognized total share-based compensation of RMB33.2 million, RMB90.8 million and RMB39.7 million, respectively, in the form of stock appreciation rights (“SARs”), restricted stock units (“RSUs”) and options awarded to our employees, and in the form of share awards as compensation to our Directors.

Summary · p. 13

The decrease in share-based compensation for our employees and Directors from 2021 to 2022 was mainly the result of (i) the cancellation of stock appreciation right awards of our executives in part and in full during the period, which resulted in a one-off reversal of the corresponding accumulated share-based compensation provided since its inception and (ii) the decrease in the number of RSUs granted and vested in 2022 compared to that in 2021.

Summary · p. 13
The company's explanation, the adviser's view and the page in the filing: see Matters
2023-02-27Prospectus
Logory Logistics Technology Co., Ltd.合肥维天运通信息科技股份有限公司02482.HK

(1) We operate share award schemes for the purpose of providing incentives and rewards to eligible participants who contribute to the success of our operations. Such share-based payments are non-cash in nature.

Summary · p. 15

Our employees (including our directors) receive remuneration in the form of share-based payments, whereby employees render services as consideration for equity instruments ("equity-settled transactions").

Financial Information · p. 375

The cost of equity-settled transactions is recognized in employee benefit expense, together with a corresponding increase in equity, over the period in which the performance and/or service conditions are fulfilled.

Financial Information · p. 375
The company's explanation, the adviser's view and the page in the filing: see Matters

Tell us